Treatment of Moderate-to-Severe Glabellar Lines With RelabotulinumtoxinA, an Investigational Liquid Botulinum Toxin: Clinical Efficacy and Safety Results From the READY-1 Phase 3 Trial

Authors:
  • NSNowell Solish
    Nowell Solish
  • AMAmir Moradi
    Amir Moradi
  • SSSachin Shridharani
    Sachin Shridharani
  • LDLisa Donofrio
    Lisa Donofrio
  • MGMichael H Gold
    Michael H Gold
  • BBBrian Biesman
    Brian Biesman
  • MCMelissa Chiang
    Melissa Chiang
  • RGRosalyn George
    Rosalyn George
  • KPKristel Polder
    Kristel Polder
  • RSRob Schwarcz
    Rob Schwarcz
  • XLXiaoming Lin
    Xiaoming Lin
  • SCSarah Coquis-Knezek
    Sarah Coquis-Knezek

Abstract
No abstract available

This publication has 1 reference indexed in Scilit: